BC
BIO icon

Bartlett & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bartlett & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-21
Closed -$2K – 689
2013
Q3 		$2K Buy
+21
New +$2.48K ﹤0.01% 720

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bartlett & Co's BIO Position: Q4 2013 in Review

Bartlett & Co sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2013, closing a stake of 21 shares — an estimated $2K sold.

Bartlett & Co first reported a position in BIO in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 198 funds tracked by Wall St. Rank hold BIO as of Q4 2013.

  • Bartlett & Co reported no remaining Bio-Rad Laboratories Class A position as of Q4 2013 after selling out during the quarter.
  • Bartlett & Co sold 21 Bio-Rad Laboratories Class A shares in Q4 2013, an estimated $2K.
  • Bartlett & Co first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 1 quarter.
  • Bartlett & Co's Bio-Rad Laboratories Class A position peaked at $2K in Q3 2013.
  • 198 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2013.

Based on Bartlett & Co's 13F filing for Q4 2013, filed 5 Feb 2014.